Amicus Therapeutics Inc (FOLD) Event Aug. 04, 2022, 00:00 UTC (75% Positive) Amicus Therapeutics, Inc. (FOLD) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 3:12 p.m. 🏢 Amicus Therapeutics Inc (FOLD) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-116.89M $-147.42M $30.53M +20.71% 📉 Total Assets $905.14M $800.59M $104.55M +13.06% 📈 Total Liabilities $597.77M $627.16M $-29.39M -4.69% ↘️ Stockholders' Equity $213.91M $-2.16B $2.38B +109.89% 📈 Operating Income/Loss $-91.89M $-135.95M $44.06M +32.41% 📉 Gross Profit $128.90M $143.67M $-14.77M -10.28% 📉 SG&A Expense $89.00M $111.50M $-22.49M -20.17% 📈 Earningspersharebasic $-0.44 $-0.51 $0.07 +13.73% 📈 Earningspersharediluted $-0.44 $-0.51 $0.07 +13.73% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Amicus Therapeutics Inc (FOLD) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document